Related by context. All words. (Click for frequent words.) 72 sulfonylhydrazine class 72 5 HT2A inverse 72 oral prodrug 71 pralatrexate injection folate analogue 70 reversible inhibitor 70 defensin mimetic antibiotic 70 Miraxion Amarin lead 70 5 HT2A serotonin 70 Tumour VDA 70 triggers apoptosis programmed 70 AAG geldanamycin analog 69 IMiDs ® 69 Cyclooxygenase Inhibiting Nitric Oxide 69 investigational humanized monoclonal antibody 69 anionic backbone 69 novel orally bioavailable 69 hypoxia selective 68 RON Notch 68 IMiDs R 68 proteasome inhibitor 68 non nucleoside inhibitor 68 dasatinib Sprycel ® 68 Enzastaurin 68 XL# anticancer compounds 68 IAP inhibitor 68 agonist compounds 68 VEGFR2 inhibitor 68 selective inverse agonist 68 M2 subunit 67 DNA methyltransferase inhibitors 67 targeted radiotherapeutic 67 Kinase Inhibitor 67 sodium glucose cotransporter 67 AKT inhibitor 67 pan histone deacetylase 67 highly selective inhibitor 67 RAS MAPK pathway 67 multi kinase inhibitor 67 Alfacell proprietary ribonuclease 67 selectively inhibits 67 histone deacetylase HDAC 67 hypoxia activated prodrug 67 alpha folate receptor 67 oral Janus kinase 67 CYT# potent vascular disrupting 67 G Protein Coupled 67 Pruvel TM 67 PEGylated Fab fragment 67 Aganocide ® 67 2 methoxyestradiol 67 PNP inhibitor 67 PDE4 inhibitor 67 activin receptor type 67 pan HDAC inhibitor 67 selective kinase inhibitor 67 vesicular monoamine transporter 66 candidate deforolimus 66 TKB# 66 5 HT4 66 Factor Receptor 66 virus HCV protease inhibitor 66 agonistic human 66 NS5b 66 novel histone deacetylase 66 SAR# [002] 66 oral dihydropyrimidine dehydrogenase DPD 66 Preclinical studies suggest 66 selective antagonist 66 PI3K/Akt pathway inhibitor 66 anti amnesic 66 MET VEGFR2 66 CYP#A# CYP#D# 66 folate analogue metabolic 66 polysaccharide polymer 66 humanized monoclonal antibody 66 Aganocide R 66 Cannabinor 66 accumulate preferentially 66 peripherally acting 66 alpha 2A adrenergic 66 FOLOTYN ® 66 ENMD # 66 inverse agonist 66 signal transduction inhibitor 66 oral proteasome inhibitor 66 Initiates Phase II 66 MTP inhibitor 66 non nucleoside HCV 65 product candidate Lpathomab 65 selective adhesion molecule 65 aurora kinase 65 Pharmos proprietary 65 MEK inhibitor 65 Janus kinase 65 ribonucleotide reductase clinically validated 65 anti botulism antibody 65 huC# DM4 65 nicotinic acetylcholine receptor 65 Janus Kinase 65 IgG1 monoclonal antibody 65 Delta opioid receptor 65 receptor tyrosine kinase inhibitor 65 delta opioid receptor 65 humanized anti 65 humanized therapeutic 65 HSP# inhibitor 65 5 HT6 65 small molecule defensin 65 sphingosine 1 65 polymerase inhibitor 65 potent topoisomerase II 65 cyclin dependent kinase inhibitor 65 novel immunomodulatory 65 potently inhibit 65 pan BCR ABL 65 Ovitrelle R Serostim 65 CB2 selective receptor agonist 65 PI3K/mTOR 65 product platforms AZX# 65 specific lectin receptors 65 chemically modified siRNA 65 mertansine 65 MCSP respectively 65 secretory phospholipase A2 65 kinase PI3K 65 ARRY # 65 cyclin dependent kinase CDK 65 proprietary polysaccharide 65 orally bioavailable 65 selective A2A adenosine receptor 65 highly selective endothelin 65 taxane derivative 65 reversible inhibitors 65 rxRNA 65 lead heptagonist compound 65 CCR2 receptor 65 OMP #R# 65 Panzem R 65 Telik logo TELINTRA 65 potently inhibited 65 modulate ion channel 65 CD4 monoclonal antibody 65 peptidic compound 65 anti miRs antisense oligonucleotide 65 platform HDL Mimetic 65 receptor modulators 65 HER1 65 XOMA 3AB biodefense 65 Protein Kinase C 65 mGluR5 negative 65 selectin antagonist 65 R roscovitine CDK cyclin 65 Initiate Phase 65 serine threonine 64 biased ligand 64 class mGluR5 inhibitor 64 irreversible inhibitor 64 histone deacetylase HDAC inhibitor 64 rHuPH# recombinant human 64 Pharmos pipeline 64 Files IND 64 Aurora Kinase 64 combines bupropion 64 cortisol synthesis 64 familial amyloidotic polyneuropathy FAP 64 dependent kinase inhibitor 64 include VALSTAR TM 64 Initiates Clinical Trial 64 EZN 64 selective agonist 64 treat chronic rhinosinusitis 64 CCR1 64 mTOR mammalian target 64 targeting CD# 64 receptor partial agonist 64 Sapacitabine 64 targets Galectin receptors 64 Locked Nucleic Acid LNA 64 hyaluronidase enzyme 64 4SC AG ISIN DE# 64 protein tyrosine phosphatase 1B 64 Receives Orphan Drug Designation 64 development peramivir neuraminidase 64 SinuNase ™ 64 liposomal formulation 64 apoptosis inducer 64 mitogen activated ERK kinase 64 oral immunomodulatory 64 novel topoisomerase 64 XL# inhibits 64 certain protein tyrosine 64 NPC 1C 64 commercializing oxidized glutathione 64 Small Molecule 64 R Saizen R 64 MKC# MT 64 histone deacetylase 64 small molecule agonists 64 activate SIRT1 64 Receptors GPCRs 64 novel VDA molecule 64 Angiocept 64 THR beta agonist 64 Darinaparsin 64 novel peptide 64 TNF Tumor Necrosis Factor 64 Phase 2b Clinical Trial 64 small molecule Hedgehog 64 peptibody 64 prostate secretory 64 pathophysiological effects 64 non porcine pancreatic 64 phosphate S1P 64 ABL inhibitor 64 Tumour Vascular Disrupting Agent 64 vapreotide acetate 64 5 HT2A receptor 64 Sudhir Agrawal D.Phil 64 antisense drug 64 Viprovex R 64 NMDA N 64 GRNOPC1 contains 64 developing Bicifadine serotonin 64 siRNA binds 64 small molecule tyrosine 64 adenosine A2A 64 telomerase therapeutic 64 neuropathic pain metabolic diseases 64 orally administered inhibitor 64 subtype selective 64 generation purine nucleoside 64 Completes Patient Enrollment 64 antiangiogenesis therapies 64 KSP inhibitor 64 erlotinib Tarceva ® 64 PDGFR B 64 non thiazolidinedione TZD 64 Rigel R# 64 enhance ApoA 64 HCV NS3 protease 64 calcitonin gene related 64 protein kinase inhibitor 64 MKC# MKC# PP 64 Novel Oral 63 ocular formulation 63 Aflibercept 63 ATRA IV 63 apoptosis proteins 63 hyperphosphorylation 63 HCV RNA polymerase 63 targets HGF FGFR 63 Panzem NCD 63 synthetic siRNA 63 small molecule inhibitor 63 CB2 receptor selective 63 tyrosine kinase receptor 63 ALTROPANE R 63 Myolimus 63 5 lipoxygenase 63 IMPDH inhibitor 63 aurora kinase inhibitor 63 peripherally restricted 63 HCV NS5B polymerase 63 sunitinib Sutent ® 63 RAF kinase 63 CD# CEA 63 gastro intestinal inflammation 63 Phase Ib clinical trials 63 Orally administered 63 Sphingomab TM 63 MSCRAMM ® 63 modified glutathione analog 63 iobenguane 63 MT#/MEDI-# 63 kidney urologic 63 novel peptides 63 hormone LHRH antagonist 63 Darapladib 63 neuronal nicotinic receptor NNR 63 cetuximab Erbitux R 63 Phase 2a Clinical Trial 63 Iluvien ® 63 DNA intercalator 63 Ostabolin C TM 63 oral ferric iron 63 synthetic cannabinoid compounds 63 poly ADP ribose polymerase 63 OMP #M# 63 silicon carbide SiC gallium 63 Tyrima 63 selective immunoproteasome inhibitor 63 Vascular Disrupting Agent 63 B lymphocyte stimulator 63 3 kinase PI3K 63 antisense oligonucleotide 63 enzyme inhibitor 63 isoform selective 63 nilotinib Tasigna ® 63 insomnia migraine headaches 63 camptothecin CPT 63 Staphylococcus aureus Immune Globulin 63 CCX# 63 epothilones 63 Presents Positive 63 Omacetaxine 63 selective serotonin 2C receptor 63 NS5B polymerase 63 potent inhibitor 63 PKC# 63 neuronal nicotinic receptors NNRs 63 AEG# 63 attach auristatin 63 anti secretory 63 mitotic kinesin 63 CK # novel 63 PTP 1B 63 Tezampanel 63 NU# direct 63 Investigational Oral 63 PDE4 63 optimized siRNA 63 TLR9 agonist 63 methyl D aspartate 63 targeted antifolate 63 Prodrug 63 IL# PE#QQR 63 Aganocide 63 DG# compounds targeting 63 ALN HPN 63 small molecule glucokinase 63 compound PMX # 63 candidates Azedra TM 63 CEA CD# Her2 63 Aptamer 63 Archexin 63 Curaxin CBLC# 63 small molecule chemotherapeutic 63 MEK ERK 63 peptidomimetic 63 receptor inhibiting monoclonal 63 deacetylase 63 metastatic colorectal 63 therapeutic monoclonal antibody 63 Crizotinib PF # 63 Epothilones 63 D aspartate NMDA receptor 63 candidate Lovaxin C 63 Civacir TM Hepatitis C 63 c Raf kinase 63 Eg5 63 Intravenous Human 62 TRIOLEX ™ 62 selective inhibition 62 inflammatory PDE 62 IMiD 62 novel antifolate 62 Pharma Merck Serono 62 investigational pan BCR 62 tiapamil 62 Solazed ™ 62 triciribine phosphate monohydrate 62 luteinizing hormone releasing 62 infectious diseases autoimmune 62 PDE# 62 vinca alkaloid 62 Talabostat 62 overactive bladder AA# 62 microsomal triglyceride transfer 62 HGS ETR1 mapatumumab 62 beta 1a 62 NS#/#A protease 62 JZP 62 tubulin inhibitor 62 label Lipofen R 62 cathepsin K inhibitor 62 Potassium Chloride Sodium Ascorbate 62 polyglutamate 62 selective androgen receptor modulator 62 Sphingomab 62 Zemiva ™ 62 protein mTOR 62 Pruvel ™ 62 MT# MEDI 62 CYC# 62 injectable formulation 62 negative allosteric modulator 62 MET RET 62 Meets Primary Endpoint 62 selective androgen receptor modulators 62 mediated apoptosis 62 Personalized Immunotherapy 62 Mg Usa 62 2A receptor agonist 62 Initiates Enrollment 62 anti CD3 monoclonal 62 CCR9 antagonist 62 Cathepsin S 62 Silodosin 62 IAP inhibitors 62 VEGF receptor 62 oral ghrelin agonist 62 intranasal formulation 62 using ImmunoGen TAP 62 modulator SERM 62 chemokine receptor 62 Systemic Delivery 62 lead Aganocide compound 62 systemically administered 62 novel therapeutic antibodies 62 induces apoptosis 62 orally dosed 62 GVAX ® 62 TLR7 agonist 62 selective phosphodiesterase 62 Romidepsin 62 Lisofylline LSF 62 selective estrogen receptor modulator 62 agent VDA 62 anti aging glycopeptides 62 Oracea TM 62 ALVESCO ® 62 Commences Phase 62 agonists antagonists 62 CYP#A# isoenzyme 62 fatty acid amide hydrolase 62 Affilin ® 62 CDK cyclin dependent 62 alkylating 62 Drug Candidate 62 Anti Tumor 62 brivanib 62 NF kB Decoy 62 aspartyl 62 related apoptosis inducing 62 5 HT2C serotonin 62 adrenergic regulation 62 BRAF kinase 62 Monoclonal Antibody 62 TRANSDUR ® 62 phosphatidylinositol 3 62 XL# XL# XL# XL# 62 infectious diseases autoimmune diseases 62 Presents Preclinical Data 62 selectively inhibit 62 inhibitor PPI 62 itraconazole Sporanox 62 acetylcholinesterase AChE 62 Liposomal 62 oral nucleoside analogue 62 generation antisense inhibitor 62 JAK inhibitor 62 Cethrin R 62 glucagon receptor 62 topically applied SEPA 62 Otelixizumab 62 proteasome inhibitors 62 PF # [002] 62 Transdrug R 62 E CENP E 62 p# mitogen activated 62 p# alpha [001] 62 5 HT2C 62 novel tubulin binding 62 Methylnaltrexone 62 diarrhea predominant irritable 62 4 PDE4 enzyme 62 immunotoxin 62 selectively induce apoptosis 62 humanized monoclonal antibodies 62 HCV protease 62 kinase inhibitor 62 candidate REP# 62 antisense inhibitors 62 molecule epidermal 62 huN# DM1 62 carbohydrate polymer 62 Bosutinib 62 Carfilzomib 62 hypoxia inducible factor 62 Annamycin 62 mecamylamine 62 acadesine 62 CD# monoclonal antibody 62 Adenosine Therapeutics 62 cholesteryl ester transfer 62 protein kinase inhibitors 62 investigational pharmacologically unique 62 Initiates Clinical 62 HDAC Inhibitor 62 candidates Azedra 62 Vidofludimus 62 novel anticancer 62 Onconase 62 PDX pralatrexate 62 RTP #i 62 peroxidase 62 lexidronam injection 62 ErbB1 62 MAbs targeting 62 Histone Deacetylase 62 humanised monoclonal antibody 62 Elotuzumab 62 topical PTH #-# 62 influenza BCX# purine nucleoside 62 cladribine Cladribine Tablets 62 TELINTRA R 62 selective modulator 62 KL4 Surfactant 62 ADP receptor antagonist 62 Custirsen 62 potently inhibits 62 clinically validated targets 62 proprietary LNA 62 humanized monoclonal 62 dasatinib Sprycel 62 Deforolimus 62 positive allosteric modulator 62 Elvitegravir 62 Vidaza ® 62 active AKT inhibitor 62 Apoptone HE# 62 5 HT3 antagonist 62 CEQ# 62 vascular disrupting agent 62 sodium thiosulfate STS 62 Submits NDA 62 triggers apoptosis 62 drug pipeline TAFA# 62 Recombinant Human 62 Solution XOPENEX HFA 61 Squalamine 61 small molecule thrombopoietin 61 myelofibrosis polycythemia vera 61 receptors PPARs 61 histone deacetylase inhibitor 61 Emergent marketed 61 investigational monoclonal antibody 61 2 inhibitor CYT# 61 cyclin dependent kinase 61 JAK1 61 Aurora kinase inhibitor 61 Luteinizing Hormone Releasing Hormone 61 metabolic inhibitor 61 Aplidin R 61 potent suppressor 61 Gamma secretase 61 cytotoxin 61 metaglidasen 61 serious systemic Staphylococcal 61 mda 7 61 Merck OSI Pharmaceuticals 61 bevacizumab Avastin ® 61 small molecule modulators 61 NNRs 61 Immunotherapeutic 61 evaluating tivozanib 61 Pentad TM 61 Solazed TM 61 Epothilone D 61 Kuvan sapropterin dihydrochloride 61 Belimumab 61 XL# XL# 61 Pimavanserin 61 Daclizumab 61 Veronate R 61 amino acid peptide 61 phosphoinositide 3 61 Preclinical Study 61 INSPIRE Trial Phase III 61 selective orally bioavailable 61 RNAi Therapeutic 61 novel synthetic peptide 61 Initiates Phase 61 Kahalalide F 61 Idera Pharmaceuticals develops 61 MPH AMEX 61 Hsp# Inhibitor 61 5 lipoxygenase activating 61 Ad5FGF 4 61 ALN PCS 61 RhuDex R 61 ThermoDox ® clinical 61 DNAi 61 pharmacogenomic translational research 61 receptor CXCR4 61 rusalatide acetate 61 docetaxel Taxotere R 61 Ostarine ™ 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 tubulin binding 61 ABLYNX 61 Advancing Drugs 61 Vitamin D analogue 61 non nucleoside 61 derivatives Radilex TM 61 Familial Adenomatous Polyposis FAP 61 antisense inhibitor 61 Maribavir 61 transient receptor 61 markets COLAZAL 61 matrix metalloproteases 61 delivers fluocinolone acetonide FA 61 vaccine GRNVAC1 61 oral isoform selective HDAC 61 inhibit oxidative stress 61 HuCAL PLATINUM ® CysDisplay 61 alkylating agent 61 selective estrogen receptor 61 Pralatrexate 61 Angiotensin Converting Enzyme 61 reformulates existing FDA 61 histone deacetylation 61 Fovea Pharmaceuticals subsidiary 61 Nasdaq VNDA 61 ERK1 2 61 novel antimitotic agent 61 PEGylated anti 61 selectively inhibited 61 allosteric modulator NAM 61 mTOR inhibitor 61 substrates inhibitors 61 kinase PI3K Akt pathway 61 PI3K inhibitor 61 imatinib Gleevec ® 61 zolpidem tartrate sublingual tablet 61 Locked Nucleic Acid 61 Homspera TM 61 ALN TTR 61 melanocortin receptor agonists 61 Therapeutic Competitors Companies 61 M# rationally 61 thrombin receptor 61 Affimed Therapeutics AG 61 clinical trials Archexin ® 61 tyrosine kinase inhibitor TKI 61 Selective Electrochemical Tumor Ablation 61 angina nausea 61 HGS# 61 targetters 61 benzothiazole 61 Nanobody 61 Initiates Phase III 61 anti angiogenic agent 61 Quinamed R 61 proprietary MSCRAMM ® 61 Raf kinase 61 siRNA therapeutic 61 Presents Preclinical 61 Reports Preclinical Data 61 Guanilib 61 R DepoCyt 61 pharmacodynamic profiles 61 antibody MT# 61 evaluating picoplatin 61 Anidulafungin 61 fosbretabulin 61 Crofelemer budesonide foam 61 recombinant fusion 61 Epeius Biotechnologies Corporation 61 AKIP ™ 61 MMAE 61 histone deacetylase HDAC inhibitors 61 gamma amino butyric 61 NEUGENE 61 interferon alpha IFN 61 Valproic acid 61 AQD class 61 estrogen receptor antagonist 61 serine protease 61 NASH Huntington 61 Elesclomol 61 polymerase inhibitors 61 oncolytic virus therapies 61 SMARTICLES ® 61 hormone LHRH 61 Phase 2b Trial 61 NicVAX TM 61 memantine HCl 61 advanced metastatic renal 61 anticancer therapeutics 61 Tesetaxel 61 NuMimetic TM 61 methionine aminopeptidase 61 iloprost synthetic compound 61 Oragens TM 61 TLK# 61 Cintredekin Besudotox 61 Begins Dosing 61 Pivotal Phase III 61 optical biosensors 61 Receptor Antagonist 61 NEUGENE antisense 61 retinoic acid receptor 61 Darinaparsin Zinapar TM 61 EOquin TM phase 61 R MSCRAMM 61 Sphingosine 1 61 IMPACS TM compounds 61 vascular disrupting agents 61 particularly SANCTURA XR 61 IGF1R 61 JAK2 inhibitor 61 serine threonine kinase 61 induced mucositis 61 IMPACS R 61 Cotara R 61 Bruton tyrosine kinase 61 Pancreate 61 LymphoStat B belimumab 61 intravesical infusion therapy 61 HepDirect prodrug 61 topoisomerase II inhibitor 61 oral dual endothelin 61 bevacizumab Avastin R 61 Novel Anticancer 61 Fx #A 61 binds selectively 61 molecular imaging radiopharmaceutical 61 Oxytrex TM 61 OXIGON TM 61 PSN# [002] 61 Humanized Anti 61 mild vasodilator 61 Tß4 61 biologic therapeutics 61 mGluR5 NAM 61 Phase 1b clinical trials 61 Monoclonal antibody 61 Teriflunomide 61 vaccines oncolytic virus 61 A3 adenosine receptor 61 stable nucleic acid 61 Crizotinib 61 prodrugs 61 TRANSDUR ™ 61 BHT DNA 61 BLyS specific 61 prostate cancer antigen prostatic 61 DNA RNA Medicines 61 GDIR 61 liposome encapsulated 61 engineered proteases 61 Indibulin ZIO 61 Long acting beta2 61 brand ciclesonide HFA 60 5 HT6 receptor 60 Nasdaq HALO 60 Stapled Peptide 60 Xcytrin R 60 Receptor Agonist 60 Mg Uk 60 SPL# Gel vaginal microbicide 60 acetylcholinesterase 60 Therapeutics Daiichi Sankyo 60 lead molecular radiotherapeutic 60 dopamine D2 60 NRGN 60 prostones 60 methylnaltrexone bromide 60 androgen receptor modulator 60 Xanafide 60 neurokinin 1 60 RDEA# potent 60 Dose Ranging Study 60 Aztreonam lysine 60 investigational oral inhibitor 60 Auxilium transmucosal film 60 small molecule 60 alkylated amino acid 60 Small Modular SMIP 60 Submits Biologics License Application 60 #HT# 60 sorafenib tablets 60 inhaled formulation 60 factor TNF 60 Anticalins R 60 engineered RAP peptides 60 XmAb ® 60 mGluR2 NAM 60 CDK inhibitor 60 essential thrombocythemia ET 60 Tumor Necrosis Factor 60 AN# topical anti 60 Perflubutane Polymer Microspheres 60 Prodarsan R 60 Unit Dose Budesonide 60 Factor VEGF 60 neuroprotective properties 60 ispinesib SB # 60 cyclooxygenase COX 60 JAK#/JAK# 60 products Oncaspar 60 anticancer compound 60 gamma secretase inhibitor 60 Immunomodulatory 60 Oral Suspension USP 60 chimeric monoclonal antibody 60 NR2B selective 60 tests miRview TM 60 VentiRx Pharmaceuticals 60 subtype selective NMDA receptor 60 acute peripheral arterial 60 Antibody Drug Conjugate 60 TO AVOID PREGNANCY WHILE 60 systemic juvenile idiopathic 60 Colaris Colaris AP 60 synthetic cannabinoid library 60 including cyclosporine methotrexate 60 RenaZorb TM 60 PEG SN# 60 dihydrochloride Tablets 60 XL# XL# XL# 60 clinical trials Archexin 60 prokinetic agent 60 small molecule VR1 60 Ixabepilone 60 6 sulfatase 60 potent anticancer 60 Nicotine Conjugate Vaccine 60 Interferon gamma 60 Ecallantide 60 Voreloxin 60 prostaglandin D2 60 telomerase reverse transcriptase 60 Cardium Therapeutics TM 60 nitride GaN 60 generation antisense 60 uroguanylin 60 Pivotal Phase 60 dual PPAR peroxisome 60 MEK inhibitors 60 Lenocta TM 60 RNA antagonists 60 docetaxel Taxotere ® 60 Pathway Inhibitor 60 Posiphen TM 60 pan Bcl 2 60 Completes Enrollment 60 Cyclooxygenase 60 oral kinase inhibitor 60 potent inhibitors 60 Obatoclax 60 Linaclotide 60 systemic RNAi therapeutic 60 drug conjugates ADCs 60 Intermezzo ® zolpidem tartrate 60 includes TOLAMBA TM 60 Exherin TM 60 Arno Therapeutics 60 Aztreonam formulated 60 XmAb ™ 60 gamma secretase inhibitors 60 reslizumab 60 developing ACAPODENE 60 resolvin 60 Belerofon 60 MAGE A3 ASCI 60 DiLA2 60 www.ucb group.com 60 novel L DOS# 60 TM Aganocide 60 generation camptothecin analogue 60 AAG KOS 60 adecatumumab MT# 60 mocetinostat MGCD# 60 Fleximer 60 Cobalamin TM mediated 60 DB# [003] 60 Tumor necrosis factor 60 Zoraxel TM 60 oral isotype selective HDAC 60 Glucagon Like Peptide 60 personalized cellular immunotherapy 60 Oral NKTR 60 NEBIDO R 60 Submits IND 60 partial agonist 60 nicotinic alpha 7 60 multicenter Phase III 60 ADMET database 60 selectively binds 60 naturally occurring neuroprotective 60 EGFR HER 60 tyrosine kinase inhibitor 60 inhibits Akt activation 60 immunomodulating 60 toenail onychomycosis 60 Safinamide 60 alpha#beta# 60 sorafenib tablets small 60 specific protein tyrosine 60 AMPA kainate 60 commercializing dermatological products 60 inhibitor COX 60 Azacitidine 60 oxidative stress inducer 60 novel chimeric natriuretic 60 drug conjugate 60 opioid receptor antagonist 60 molecular imaging radiopharmaceuticals 60 sapropterin dihydrochloride Phase 60 delivered RNAi therapeutic 60 CysDisplay R 60 thalidomide Thalomid 60 PPAR peroxisome proliferator activated 60 selectively inhibit replication 60 long acting muscarinic 60 class anticancer quinolone 60 Inc. Amex PRW 60 antibody fragment 60 thyroid hormone receptor 60 DURECT proprietary 60 selective inhibitor 60 selective angiogenic kinase inhibitor 60 preclinically 60 HER pathway 60 TRPV1 agonist 60 kinesin spindle protein 60 orally inhaled 60 Injectable Suspension 60 patented Bioral 60 lintuzumab SGN 60 GW# [003] 60 topoisomerase 60 HDACi 60 mGluR4 60 PI3K inhibitors 60 generation proteasome inhibitor 60 R#/MEM # 60 Licenses Novel 60 mGluR2 positive 60 mu opioid receptor antagonist 60 Announces Tentative Approval 60 monoclonal antibody MAb 60 Zorbtive TM 60 Genasense ® oblimersen 60 selective adenosine 60 Hypoxia Inducible Factor 60 HER2 HER2 60 Peptide YY 60 Present Preclinical Data 60 Aurora kinase 60 antimitotic 60 BiTE ® 60 PrevOnco 60 mTOR kinase 60 adhesion molecule EpCAM expressing 60 High Impact AMPAKINE 60 Beta catenin 60 CFTR cystic fibrosis transmembrane 60 alpha TNFa 60 ELADUR ™ 60 nitric oxide donating 60 Peroxisome Proliferator Activated Receptor 60 c MET 60 treat chronic sinusitis 60 topical gel formulation 60 androgen receptor AR 60 Exelixis compounds 60 progressive metastatic prostate 60 directed radiotherapeutic antibody 60 Anticalin 60 Biopharmaceuticals AG 60 FGFR 60 metabotropic glutamate receptor 60 Spiegelmer ® 60 Denufosol 60 initiated Phase Ib 60 Anticancer Compound 60 receptor inhibitor 60 R sorafenib tablets 60 TNF alpha selectively neutralizing 60 potent antiproliferative 60 topical non steroidal 60 HQK 60 oral JAK1 60 gets USFDA nod 60 Nventa proprietary CoVal 60 TLR8 60 humanized interleukin 6 60 CYT# vascular disrupting 60 First Patient Dosed 60 PRLX # 60 Ep CAM 60 nucleoside analog 60 therapeutic monoclonal antibodies 60 psoriasis rheumatoid arthritis 60 Luveris R Ovidrel R 60 Factor VIIa 60 GlycoPEGylated hemostasis compounds 60 Serdaxin ® 60 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 60 Pafuramidine 60 potential vanilloid 60 XOMA 3AB 60 Fc fusion protein 60 chemically modified tetracyclines 60 Locteron combines 60 ALN TTR#